{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T20:45:17Z","timestamp":1789073117687,"version":"build-2803163510"},"reference-count":33,"publisher":"Public Library of Science (PLoS)","issue":"4","license":[{"start":{"date-parts":[[2013,4,18]],"date-time":"2013-04-18T00:00:00Z","timestamp":1366243200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0061514","type":"journal-article","created":{"date-parts":[[2013,4,18]],"date-time":"2013-04-18T21:14:52Z","timestamp":1366319692000},"page":"e61514","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":15,"title":["Pharmacokinetics and Interspecies Allometric Scaling of ST-246, an Oral Antiviral Therapeutic for Treatment of Orthopoxvirus Infection"],"prefix":"10.1371","volume":"8","author":[{"given":"Adams","family":"Amantana","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yali","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shanthakumar R.","family":"Tyavanagimatt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin F.","family":"Jones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Jordan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jarasvech","family":"Chinsangaram","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tove\u2032 C.","family":"Bolken","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janet M.","family":"Leeds","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dennis E.","family":"Hruby","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2013,4,18]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1177\/135965350701200802","article-title":"Activity of the anti-orthopoxvirus compound ST-246 against vaccinia, cowpox and camelpox viruses in cell monolayers and organotypic raft cultures","volume":"12","author":"S Duraffour","year":"2007","journal-title":"Antiviral Ther"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1128\/AAC.00879-06","article-title":"Efficacy of delayed treatment with ST-246 given orally against systemic orthopoxvirus infections in mice","volume":"51","author":"DC Quenelle","year":"2007","journal-title":"Antimicrob Agents and Chemother"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"768","DOI":"10.4269\/ajtmh.2007.76.768","article-title":"Efficacy of the antipoxvirus compound ST-246 for treatment of severe orthopoxvirus infection","volume":"76","author":"E Sbrana","year":"2007","journal-title":"Am J Tropical Med and Hyg"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.antiviral.2008.03.005","article-title":"Evaluation of orally delivered ST-246 as postexposure prophylactic and antiviral therapeutic in an aerosolized rabbitpox rabbit model","volume":"79","author":"A Nalca","year":"2008","journal-title":"Antiviral Res"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"2620","DOI":"10.1128\/AAC.00021-09","article-title":"Nonhuman primates are protected from smallpox virus or monkeypox virus challenges by the antiviral drug ST-246","volume":"53","author":"J Huggins","year":"2009","journal-title":"Antimicrob Agents and Chemother"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1128\/AAC.01596-08","article-title":"ST-246 antiviral efficacy in a nonhuman primate monkeypox model: determination of the minimal effective dose and human dose justification","volume":"53","author":"R Jordan","year":"2009","journal-title":"Antimicrob Agents and Chemother"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"13139","DOI":"10.1128\/JVI.79.20.13139-13149.2005","article-title":"An orally bioavailable antipoxvirus compound (ST-246) inhibits extracellular virus formation and protects mice from lethal orthopoxvirus challenge","volume":"79","author":"G Yang","year":"2005","journal-title":"J of Virol"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1743-422X-6-44","article-title":"Vaccinia virus p37 interacts with host proteins associated with LE-derived transport vesicle biogenesis","volume":"6","author":"Y Chen","year":"2009","journal-title":"Virol J"},{"key":"ref9","first-page":"228","article-title":"Risks, regulation, and rewards in new drug development in the United States","volume":"19","author":"JA DiMasi","year":"1994","journal-title":"RegulToxicol Pharmacol"},{"key":"ref10","first-page":"541","article-title":"Drug research: from the idea to the product","volume":"35","author":"J Kuhlmann","year":"1997","journal-title":"Int J Clin.Pharmacol Ther"},{"key":"ref11","first-page":"777","article-title":"Some fundamental considerations of the applications of pharmacokinetics to cancer chemotherapy","volume":"59","author":"KB Bischoff","year":"1975","journal-title":"Cancer Chemother Rep"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1007\/BF01059263","article-title":"Physiologically based pharmacokinetics of drug-drug interaction: a study of tolbutamide-sulfonamide interaction in rats","volume":"10","author":"O Sugita","year":"1982","journal-title":"J Pharmacokinet Biopharm"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1007\/BF01062546","article-title":"Physiological pharmacokinetics of ethoxybenzamide based on biochemical data obtained in vitro as well as on physiological data","volume":"10","author":"JH Lin","year":"1982","journal-title":"J Pharmacokinet Biopharm"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1007\/BF01065258","article-title":"Physiological pharmacokinetic modeling of cis-dichlorodiammineplatinum(II) (DDP) in several species","volume":"14","author":"FG King","year":"1986","journal-title":"J. Pharmacokinet Biopharm"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.3109\/00498259009046839","article-title":"Interspecies scaling and comparisons in drug development and toxicokinetics","volume":"20","author":"RM Ings","year":"1990","journal-title":"Xenobiotica"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/0742-8413(92)90003-P","article-title":"The allometric approach for interspecies scaling of pharmacokinetic parameters","volume":"103","author":"WA Ritschel","year":"1992","journal-title":"Comp Biochem Physiol C"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1007\/BF01062336","article-title":"Interspecies scaling, allometry, physiological time, and the ground plan of pharmacokinetics","volume":"10","author":"H Boxenbaum","year":"1982","journal-title":"J Pharmacokinet Biopharm"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2165\/00003088-199936010-00001","article-title":"The pharmacokinetic principles behind scaling from preclinical results to phase I protocols","volume":"36","author":"I Mahmood","year":"1999","journal-title":"Clin Pharmacokinet"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"211","DOI":"10.2165\/00003088-199936030-00003","article-title":"Prediction of hepatic metabolic clearance based on interspecies allometric scaling techniques and in vitro-in vivo correlations","volume":"36","author":"T Lave","year":"1999","journal-title":"Clin Pharmacokinet"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"887","DOI":"10.3109\/00498259609052491","article-title":"Interspecies scaling: predicting clearance of drugs in humans. Three different approaches","volume":"26","author":"I Mahmood","year":"1996","journal-title":"Xenobiotica"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/BF01065191","article-title":"Interspecies variation in liver weight, hepatic blood flow, and antipyrine intrinsic clearance: extrapolation of data to benzodiazepines and phenytoin","volume":"8","author":"H Boxenbaum","year":"1980","journal-title":"J Pharmacokinet Biopharm"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1021\/js950400y","article-title":"Interspecies scaling: predicting pharmacokinetic parameters of antiepileptic drugs in humans from animals with special emphasis on clearance","volume":"85","author":"I Mahmood","year":"1996","journal-title":"J Pharm Sci"},{"key":"ref23","unstructured":"Sacher GA (1959) Relation of life span to brain weight and body weight in mammals. In: Wolstenholme GEW, O\u2019Connor M, editors. The Lifespan of Animals. London: Little, Brown and Company. pp. 115\u2013133."},{"key":"ref24","unstructured":"Guidance for Industry, Bioanalytical Method Validation, U.S. Department of Health and Human Services, Food and Drug Administration, May 2001."},{"key":"ref25","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1023\/A:1018943613122","article-title":"Physiological parameters in laboratory animals and humans","volume":"10","author":"B Davies","year":"1993","journal-title":"Pharm.Res"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1177\/0091270003254631","article-title":"Selection of the first-time dose in humans: comparison of different approaches based on interspecies scaling of clearance","volume":"43","author":"I Mahmood","year":"2003","journal-title":"J Clin Pharmacol"},{"key":"ref27","first-page":"1","article-title":"U.S. Food and Drug Administration: Guidance for industry: estimating the maximum safe starting dose in initial clinical trials for therapeutics in adult healthy volunteers","volume":"2005","journal-title":"Fed Reg"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/0024-3205(96)00339-6","article-title":"Interspecies scaling: a comparative study for the prediction of clearance and volume using two or more than two species","volume":"59","author":"I Mahmood","year":"1996","journal-title":"Life Sci"},{"key":"ref29","unstructured":"Mahmood I (2005) Interspecies scaling of clearance. In: Mahmood, I, editor. Interspecies Pharmacokinetic Scaling: Principles and Application of Allometric Scaling. Rockville, MD. Pine House Publishers. pp. 39\u201385."},{"key":"ref30","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1208\/ps030429","article-title":"Allometric scaling of xenobiotic clearance: uncertainty versus universality","volume":"3","author":"TM Hu","year":"2001","journal-title":"AAPS PharmSci"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1002\/jat.2550090509","article-title":"Predicting toxicokinetic parameters in humans from toxicokinetic data acquired from three small mammalian species","volume":"9","author":"K Bachmann","year":"1989","journal-title":"J Appl Toxicol"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/S0022-3565(24)36999-X","article-title":"The prediction of human pharmacokinetic parameters from preclinical and in vitro metabolism data","volume":"283","author":"RS Obach","year":"1997","journal-title":"J Pharmacol Exp Ther"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1002\/j.1552-4604.1995.tb04011.x","article-title":"First time in human dose selection: allometric thoughts and perspectives","volume":"35","author":"H Boxenbaum","year":"1995","journal-title":"J Clin Pharmacol"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0061514","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,30]],"date-time":"2025-04-30T05:48:16Z","timestamp":1745992096000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0061514"}},"subtitle":[],"editor":[{"given":"Anand S.","family":"Mehta","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2013,4,18]]},"references-count":33,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2013,4,18]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0061514","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,4,18]]}}}